With over 500 published peer reviewed papers, Molecular Hydrogen is coming to the attention of the medical world with it’s many unique properties, improving symptoms related to conditions affecting nearly all of the body’s organs. Its actions are varied and most noticeably include being a powerful selective anti-oxidant and potent anti-inflammatory agent with an ability to cross the blood brain barrier and enhance mitochondrial function. Molecular hydrogen therapy has shown great improvement in a vast range of clinical settings ranging from reducing symptoms and managing the progression of diseases such as Parkinson’s Disease and Rheumatoid Arthritis through to improving athletic performance. This webinar will discuss the current research on molecular hydrogen, its specific unique functions and actions and the options available for delivery of molecular hydrogen in a clinical setting.
(Presented March 2017)
Length: 65 minutes
Presenter: Dr Elen ApThomas, MBBS DRANZCOG MACNEM
Q & A Session included
CPE Points: Please click here for more information.